A commonly used prescription antidepressant medication is being recalled because it may contain a carcinogenic substance, the Food and Drug Administration announced.
New Jersey-based Breckenridge Pharmaceutical, Inc., is recalling 14,729 bottles of duloxetine delayed-release capsules in 30-milligram doses, contained in 1,000-count bottles, according to a notice that was published on the FDA’s recall database this week. The medication has an expiration date of April 2027 with a lot number of 241180C.
The medication was manufactured by Towa Pharmaceutical Europe in Barcelona, Spain, and distributed by Breckenridge Pharmaceutical, the notice said. Neither company issued a press release for the recall.
Duloxetine, which is commonly sold under the Cymbalta brand, is used to treat depression, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain, according to the Mayo Clinic. Drug database website ClinCalc listed it as the 31st most commonly prescribed drug in the United States, with more than 18 million estimated prescriptions for the medication for about 4.2 million patients in 2023. …